Considering metformin in cardiometabolic protection in psychosis

Acta Psychiatrica Scandinavica

Volumn 126, Issue 4, 2012, Pages 302-303

  Curtis, J ^a,b   Newall, H ^b   Myles, N ^b   Shiers, D ^c   Samaras, K ^d,e  

^a Eastern Suburbs Mental Health Programme   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c National Early Intervention in Psychosis Programme   (United Kingdom)

^d ST VINCENT S HOSPITAL   (Australia)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; METFORMIN; NEUROLEPTIC AGENT;

CARDIOMETABOLIC RISK; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EATING HABIT; GLUCOSE METABOLISM; HEART DISEASE; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OVARY POLYCYSTIC DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOSIS; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SIDE EFFECT; WAIST CIRCUMFERENCE; WEIGHT GAIN; WEIGHT REDUCTION;

ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; OBESITY; PSYCHOTIC DISORDERS; WEIGHT GAIN;

EID: 84866309609     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2012.01906.x     Document Type: Note

References (5)

1. Brown S, Kim M, Mitchell C et al. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010;196:116-21.
2. Foley DL, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry 2011;68:609-616.
3. Manu P, Correll C, Van Winkel R et al. Prediabetes in patients treated with antipsychotic drugs. J Clin Psychiatry, 2012;73:460-466.
4. Vancampfort D, Probst M, Sweers K et al. Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatr Scand 2011;123:423-30.
5. Newall H, Myles N, Ward PB et al. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review. Int Clin Psychopharmacol 2012;27:69-75.